Regular exercise can help improve cardiovascular health and can complement the effects of this medication
Patient D: No insurance, compounded tirzepatide
PubMed laboratory research record [PMID: 34324435] PubMed record related to this compound for laboratory literature review
Use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of pancreatitis (adjusted HR, 9.09 [95% CI, 1.25-66.00]), bowel obstruction (HR, 4.22 [95% CI, 1.02-17.40]), and gastroparesis (HR, 3.67 [95% CI, 1.15-11.90) but not biliary disease (HR, 1.50 [95% CI, 0.89-2.53])
It is not intended for human consumption, medical diagnosis, treatment, or prevention of any disease